The Effect of Brimonidine

• Status: Completed
• Trial end date: 2019-07-20
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate whether pre-treating patients with Brimonidine 0.2% before and/or after dilating the pupils will help to control the changes in intraocular pressure often seen when using dilating drops. The study will also evaluate the effects of different sequences of administering dilating drops along with Brimonidine on pupil size and reactivity.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Wake Forest University Health Sciences
• Treatments: Brimonidine Tartrate; Oxymetazoline; Phenylephrine; Tropicamide

Criteria

Inclusion Criteria:

• Healthy individuals

• Females of childbearing potential must agree to use a reliable method of birth control while participating in the study.

Exclusion Criteria:

• Diabetic

• Have a history of glaucoma

• Have a history of iris trauma

• Have a history of eye surgery except for LASIK or PRK

• Pregnant

• Anisocoria (unequal pupils)